ABSTRACT
We present an experimental technique for a complete characterization of entanglement in a two-qutrit state generated using transverse spatial correlations of two parametric down-converted photons. We verify entanglement for a particular case via entanglement witness operators which are decomposed into a sum of local observables of single path and superposition projection operators. Experimentally, these operators are accomplished by using a spatial light modulator and a polarizing beam splitter which allow to modulate the amplitude of individually chosen path states. The quantification of entanglement is computed by the negativity obtained from the expectation values of the entanglement witnesses implemented.
Subject(s)
Computer Simulation , Light , Models, Theoretical , Photons , Scattering, Radiation , HumansABSTRACT
A model was developed to assess the lifetime costs and outcomes associated with haemophilia in Mexico. A retrospective chart review of 182 type A haemophiliacs was conducted for patients aged 0-34 years receiving one of three treatments: (i) cryoprecipitate at clinic; (ii) concentrate at home; or (iii) concentrate at clinic. Patients treated at home experienced 30% less joint damage, used 13-54% less factor VIII, had four times fewer clinic visits, and utilized half as many hospital days than those treated at a clinic. For cryoprecipitate at clinic patients, the annual incidence rates of HCV and HIV were calculated to be 3.6% and 1.4% respectively. The life expectancy for patients receiving cryoprecipitate and those receiving concentrate was estimated to be 49 years and 69 years respectively, with 58% of cryoprecipitate patients predicted to die of AIDS before age 69. Across the lifespan, the average annual cost of care was US$11,677 (MN$110,464) for cryoprecipitate at clinic patients, US$10,104 (M$95,580) for concentrate at home patients and US$18,819 (MN$178,027) for concentrate at clinic patients. Using a 5% discount rate, the incremental lifetime cost per year of life added for treatment with concentrate at home compared with cryoprecipitate at a clinic was US$738 (MN$6981). Rank order stability analysis demonstrated that the model was most sensitive to the cost of fVIII. These results indicate that treatment with concentrate at home compared with cryoprecipitate at a clinic substantially improves clinical outcomes at reduced annual cost levels.
Subject(s)
Hemophilia A/economics , Adolescent , Adult , Child , Child, Preschool , Cost of Illness , Costs and Cost Analysis , Disabled Persons , Factor VIII/economics , Fibrinogen/economics , Health Resources/economics , Humans , Infant , Infant, Newborn , Life Expectancy , Mexico , Models, Economic , Regression Analysis , Residence Characteristics , Retrospective Studies , Risk FactorsABSTRACT
There is little information concerning the use of rare earths as dopants of Al2O3. This paper presents the preparation method and the results of studying the thermoluminescence characteristics of Al2O3:Eu exposed to ultraviolet light. Phosphor powder was obtained by the evaporation method. Optimum dopant concentration was 10% at an evaporation temperature of 700 degrees C. The powder obtained was submitted to thermal treatments at high temperatures in order to stabilise the traps. Diffraction patterns showed amorphous powder up to 500 degrees C; as the temperature was raised crystalline phases of Al2O3 appeared. The photoluminescence spectrum induced by 250 nm UV light exhibited four well defined peaks characteristic of the Eu3+ ion. The glow curve exhibited two peaks at 180 and 350 degrees C. The sensitivity of Al2O3:Eu was 10 times lower than Al2O3:C. The thermoluminescence response was linear from 2.4 to 3000 microJ.cm(-2) of spectral irradiance, and the fading 2% in a month. From these results it can be concluded that Al2O3:Eu has potential as an UV dosemeter.
Subject(s)
Aluminum Oxide/radiation effects , Thermoluminescent Dosimetry/methods , Aluminum Oxide/chemistry , Aluminum Oxide/isolation & purification , Europium/chemistry , Hot Temperature , Luminescent Measurements , Radiochemistry , Ultraviolet RaysABSTRACT
DNA samples from seven G-6-PD deficient Mexican mestizo patients were analyzed. Three different G-6-PD genotypes were observed: G-6-PD A-202A/376G (three patients), G-6-PD A-376G/968C (three patients) and G-6-PD Seattle844C. The present results, along with previous reports, suggest not only G-6-PD A-genotypes are relatively common but also G-6-PD deficiency seems to be heterogeneous at DNA level in Mexico.
Subject(s)
Glucosephosphate Dehydrogenase Deficiency/genetics , Glucosephosphate Dehydrogenase/genetics , Africa/ethnology , DNA Mutational Analysis , Genetic Testing , Genotype , Glucosephosphate Dehydrogenase Deficiency/epidemiology , Glucosephosphate Dehydrogenase Deficiency/ethnology , Humans , Italy/ethnology , Male , Mexico/epidemiology , Spain/ethnologyABSTRACT
Se plantea la cirugía abierta como una alternativa en el tratamiento de la Hipertrofia prostática con el objetivo de resolver los problemas de la obstrucción urinaria clínica anatómica y funcionalmente. Conociendo algunas de las indicaciones se enumeran tres modalidades de cirugía abierta, se resaltan aspectos según la patología concomitante para escoger la técnica más efectiva y el menor número de complicaciones y los resultados logren el objetivo planteado
Subject(s)
Prostatic Hyperplasia/surgery , Prostatic Hyperplasia/diagnosisABSTRACT
Hb alterations studied throughout 2 years in 129 patients are reported, these patients had hemolytic anemia or the possibility of a hemoglobinopathy : 5 were heterozygotes to thalassemia b; 3 were compound-heterozygote of thalassemia a1 and thalassemia a2; 2 for thalassemia b and 2 for thalassemia b and Hb S; 2 homozygotes and 2 heterozygotes for Hb S; 2 was bearing unstable Hb and the other had Hereditary Persistence of Hb F. These results allow the conclusion that thalassemia is the Hb alteration which most frequently causes hemolytic anemia in our population and underscores the importance of the study of these pathologies in selected populations.
Subject(s)
Anemia, Hemolytic/etiology , Hemoglobinopathies/complications , Hemoglobins/analysis , Anemia, Hemolytic/blood , Female , Genotype , Hemoglobinopathies/blood , Hemoglobinopathies/epidemiology , Hemoglobins/genetics , Humans , Male , Mexico/epidemiology , Thalassemia/complications , Thalassemia/epidemiologyABSTRACT
Se presenta el caso de un paciente del sexo masculino, con anomalia leucocitaria de Pelger-Huet, entidad hereditaria que se transmite en forma autosomica dominante, caracterizada por segmentacion incompleta de los nucleos de los leucocitos y condensacion anormal de la cromatina nuclear.Se discuten las caracteristicas clinicas y de evolucion de esta enfermedad, enfantizandose en su frecuencia de presentacion y en el consejo genetico que debe ser proporcionado a los pacientes detectados